Type 2 Diabetic Medication Regimen in Treating Depression and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Veterans Using PHQ-9 and FIB-4 Scores

被引：0
|
作者：
Ubalde, Shannen Nicole
Khoury, Jessica
Davis, Jessica
Sen, Sabyasachi
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1889-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1889-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Limitations of FIB-4 Score in Excluding Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Bentley, Blake
    Ventura, Frank
    Obermmiller, Corey
    Russo, Mark
    Rudnick, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1380 - S1380
  • [2] Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease
    Bera, Chinmay
    Hamdan-Perez, Nashla
    Kosick, Heather Mary-Kathleen
    Shengir, Mohamed
    Sebastiani, Giada
    Patel, Keyur
    CANADIAN LIVER JOURNAL, 2025, 0 (AOP):
  • [3] CLINICAL MANAGEMENT OF DISCREPANCIES BETWEEN FIB-4 AND LIVER STIFFNESS MEASUREMENT IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Rabbat, Joseph
    Lee, Hye Won
    Yip, Terry Cheuk-Fung
    Lin, Huapeng
    Tsochatzis, Emmanuel
    Petta, Salvatore
    Bugianesi, Elisabetta
    Yoneda, Masato
    Zheng, Ming-Hua
    Hagstrom, Hannes
    Boursier, Jerome
    Calleja, Jose Luis
    Goh, George Boon-Bee
    Chan, Wah Kheong
    Gallego-Duran, Rocio
    Sanyal, Arun
    de Ledinghen, Victor
    Newsome, Philip
    Fan, Jian-Gao
    Castera, Laurent
    Lai, Michelle
    Fournier, Celine
    Wong, Grace
    Pennisi, Grazia
    Armandi, Angelo
    Nakajima, Atsushi
    Liu, Wen-Yue
    Shang, Ying
    Saint Loup, Marc De
    Llop, Elba
    Teh, Kevin
    Romero, Carmen Lara
    Asgharpour, Amon
    Mahgoub, Sara
    Chan, Mandy
    Canivet, Clemence
    Romero-Gomez, Manuel
    Kim, Seung Up
    HEPATOLOGY, 2024, 80 : S566 - S567
  • [4] FIB-4 Index and Liver Stiffness Measurement are Potential Predictors of Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kubotsu, Yoshihito
    Sakamoto, Yoshiko
    Tago, Motoko
    Chihara, Atsuko
    Norita, Misa
    Inadomi, Chika
    Inoue, Kaori
    Takayanagi, Hiroki
    Tanaka, Kenichi
    Isoda, Hiroshi
    Kuwashiro, Takuya
    Oeda, Satoshi
    Shiratori, Toshiyasu
    Anzai, Keizo
    Node, Koichi
    Takahashi, Hirokazu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025, 32 (02) : 239 - 252
  • [5] Longitudinal changes of FIB-4 do not predict outcomes in patients with metabolic dysfunction-associated steatotic liver disease
    Hegmar, Hannes
    Therneau, Terry
    Udompap, Prowpanga
    Canning, Rachel
    Yin, Jun
    Dierkhising, Ross
    Benson, Joanne
    Allen, Alina M.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S504 - S504
  • [6] Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kang, Yeo-Wool
    Baek, Yang-Hyun
    Moon, Sang-Yi
    DIAGNOSTICS, 2024, 14 (22)
  • [7] Diagnostic performances of FIB-4 and NFS in metabolic dysfunction-associated steatotic liver disease in primary care clinic of Asia
    Yoon, Eileen
    An, Jihyun
    Il Kim, Ha
    Sohn, Joo Hyun
    Kang, Bo-Kyeong
    Jang, Eun Chul
    Park, Huiyul
    Kim, Hye-Lin
    Ahn, Sang Bong
    Oh, Joo Hyun
    Lee, Hyo Young
    Jun, Dae Won
    JOURNAL OF HEPATOLOGY, 2024, 80 : S553 - S553
  • [8] FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
    Albert, Stewart G.
    Wood, Emily M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (07)
  • [9] FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
    Avares-da-Silva, Mario Reis
    Vargas, Marcia da Silva
    Rabie, Soheyla Mohd Souza
    Jonko, Gabriella
    Riedel, Patricia Gabriela
    Longo, Larisse
    Goncalves, Marcelo Rodrigues
    Luft, Vivian Cristine
    Joveleviths, Dvora
    ANNALS OF HEPATOLOGY, 2025, 30 (01)
  • [10] The use of ELF test, FIB-4 and sequential algorithms to screen the Type 2 Diabetes Mellitus (T2DM) population for advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Pei, Yiying
    Sng, Wei Kwan
    Quah, Joanne Hui Min
    Liu, Jin
    Chong, Bee Yen
    Lee, Hwee Khim
    Wang, Xue Fei
    Tan, Ngiap Chuan
    Chang, Jason Pik Eu
    Tan, Hong Chang
    Bee, Yong Mong
    Goh, George Boon Bee
    JOURNAL OF HEPATOLOGY, 2024, 80 : S525 - S525
12345